A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

April 11, 2025

Study Completion Date

March 15, 2026

Conditions
Atopic Dermatitis
Interventions
COMBINATION_PRODUCT

Rocatinlimab Prefilled Syringe

Prefilled Syringe (PFS) for subcutaneous (SC) injection self-administration of rocatinlimab.

COMBINATION_PRODUCT

Rocatinlimab AI

AI for SC injection self-administration of rocatinlimab.

Trial Locations (47)

15355

Korea University Ansan Hospital, Ansan-si, Gyeonggi-do

16499

Ajou University Hospital, Suwon-si, Gyeonggi-do

23502

Virginia Dermatology and Skin Cancer Center, Norfolk

27103

The Skin Surgery Center for Clinical Research, Winston-Salem

30022

Hamilton Research, LLC, Alpharetta

33012

Direct Helpers Research Center, Hialeah

33176

Anchor Medical Research, Miami

37076

Cumberland Skin Center, Hermitage

43209

Bexley Dermatology Research, Bexley

44124

Apex Clinical Research Center LLC, Mayfield Heights

57702

Health Concepts, Rapid City

66211

Dermatology and Skin Cancer Center Leawood, Leawood

74137

Essential Medical Research LLC, Tulsa

75025

Texas Dermatology Research Center, Plano

75149

Sms Clinical Research Limited Liability Company, Mesquite

83706

Treasure Valley Medical Research, Boise

89030

Las Vegas Clinical Trials, North Las Vegas

89109

Excel Clinical Research, Las Vegas

89509

Skin Cancer and Dermatology Institute, Reno

90045

Dermatology Research Associates, Los Angeles

90805

Long Beach Research Institute, Long Beach

91105

Havana Research Institute Inc, Pasadena

93301

Kern Research Inc, Bakersfield

95815

Integrative Skin Science and Research, Sacramento

V1W 4V5

Interior Dermatology Centre, Kelowna

L8L 3C3

LEADER Research, Hamilton

L3P 1X3

Lynderm Research Inc, Markham

L4Y 4C5

DermEdge Research Incorporated, Mississauga

L2H 1H5

Allergy Research Canada Incorporated, Niagara Falls

P1B 3Z7

North Bay Dermatology Centre, North Bay

K2C 3N2

Dermatology Ottawa Research Centre, Ottawa

M4E 1R7

FACET Dermatology, Toronto

N2J 1C4

Alliance Clinical Trials, Waterloo

N8T 1E6

XLR8 Medical Research, Incorporated, Windsor

S7K 2C1

Skinsense Medical Research, Saskatoon

812-0013

Ekihigashi Dermatology Allergy Clinic, Fukuoka

814-0180

Fukuoka University Hospital, Fukuoka

819-0373

Matsuo Clinic, Fukuoka

862-0950

Suizenji Dermatology Clinic, Kumamoto

593-8324

Dermatology and Ophthalmology Kume Clinic, Sakai-shi

108-0014

Mita Dermatology Clinic, Minato-ku

160-8582

Keio University Hospital, Shinjuku-ku

03722

Severance Hospital Yonsei University Health System, Seoul

05278

Kyung Hee University Hospital at Gangdong, Seoul

05505

Asan Medical Center, Seoul

06591

The Catholic University of Korea Seoul St Marys Hospital, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY